Company Filing History:
13 out of 262 
1 out of 755 
Years Active: 2014-2025
Title: The Innovative Contributions of Benjamin S. Bleier
Introduction
Benjamin S. Bleier is a prominent inventor based in Weston, MA, known for his significant contributions to medical science, particularly in the treatment of rhinosinusitis. With a total of 13 patents to his name, Bleier has made strides in developing methods and compositions aimed at diagnosing and treating diseases associated with inflammation of the sinuses and nasal cavity. His work has had a profound impact on the field of otolaryngology.
Latest Patents
Among his latest patents, Bleier has developed methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity. One notable patent focuses on the treatment of rhinosinusitis using topical verapamil. Another significant patent involves the use of P-glycoprotein inhibitors for treating rhinosinusitis. This method identifies subjects with rhinosinusitis and administers an effective amount of a P-gp inhibitor, which can be delivered through various means such as inhalation devices or surgical implants. The efficacy of these treatments can be monitored using established methods, ensuring that patients receive optimal care.
Career Highlights
Bleier has worked with esteemed institutions such as Massachusetts Eye and Ear Infirmary and Northeastern University. His career is marked by a commitment to advancing medical treatments and improving patient outcomes through innovative research and development.
Collaborations
Throughout his career, Bleier has collaborated with notable professionals in the field, including Angela Nocera and Mansoor M. Amiji. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Benjamin S. Bleier's innovative work in the field of medical science, particularly in treating rhinosinusitis, showcases his dedication to improving healthcare through invention. His numerous patents reflect a commitment to advancing treatment options and enhancing patient care.